Insider Selling: Jeffrey William Henderson Sells 78,637 Shares of Cardinal Health Stock (CAH)
Cardinal Health (NYSE:CAH) CFO Jeffrey William Henderson sold 78,637 shares of the stock in a transaction that occurred on Monday, August 18th. The shares were sold at an average price of $72.06, for a total transaction of $5,666,582.22. Following the completion of the sale, the chief financial officer now directly owns 67,190 shares of the company’s stock, valued at approximately $4,841,711. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.
A number of analysts have recently weighed in on CAH shares. Analysts at Argus reiterated a “buy” rating on shares of Cardinal Health in a research note on Monday. They now have a $71.43 price target on the stock, down previously from $83.00. Separately, analysts at Barclays reiterated an “overweight” rating on shares of Cardinal Health in a research note on Tuesday, August 5th. They now have a $82.00 price target on the stock, up previously from $77.00. Finally, analysts at Credit Suisse reiterated an “outperform” rating on shares of Cardinal Health in a research note on Tuesday, August 5th. They now have a $80.00 price target on the stock, up previously from $76.00. Three equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus target price of $77.93.
Cardinal Health (NYSE:CAH) traded up 0.54% during mid-day trading on Tuesday, hitting $72.60. The stock had a trading volume of 1,824,200 shares. Cardinal Health has a one year low of $49.65 and a one year high of $74.40. The stock has a 50-day moving average of $71.03 and a 200-day moving average of $69.58. The company has a market cap of $24.441 billion and a price-to-earnings ratio of 21.37.
Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Monday, August 4th. The company reported $0.83 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.81 by $0.02. The company had revenue of $2.90 billion for the quarter, compared to the consensus estimate of $21.88 billion. During the same quarter in the prior year, the company posted $0.79 earnings per share. The company’s quarterly revenue was down 9.9% on a year-over-year basis. On average, analysts predict that Cardinal Health will post $4.25 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Wednesday, October 15th. Investors of record on Wednesday, October 1st will be given a dividend of $0.3425 per share. This represents a $1.37 dividend on an annualized basis and a yield of 1.89%. The ex-dividend date of this dividend is Monday, September 29th.
Cardinal Health, Inc is a healthcare services company providing pharmaceutical and medical products and services to pharmacies, hospitals, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.